S3024 Risks of Gastrointestinal Malignancies in Short Bowel Syndrome Patients Treated With Teduglutide: Results From TriNetX

S3024 Risks of Gastrointestinal Malignancies in Short Bowel Syndrome Patients Treated With Teduglutide: Results From TriNetX is a paper indexed in ScholarIQ from OpenAlex.

How many citations does S3024 Risks of Gastrointestinal Malignancies in Short Bowel Syndrome Patients Treated With Teduglutide: Results From TriNetX have?

S3024 Risks of Gastrointestinal Malignancies in Short Bowel Syndrome Patients Treated With Teduglutide: Results From TriNetX has 1 citations in the OpenAlex counts ScholarIQ stores.

When was S3024 Risks of Gastrointestinal Malignancies in Short Bowel Syndrome Patients Treated With Teduglutide: Results From TriNetX published?

S3024 Risks of Gastrointestinal Malignancies in Short Bowel Syndrome Patients Treated With Teduglutide: Results From TriNetX has 2025 year in the ScholarIQ index.

What is the open-access status of S3024 Risks of Gastrointestinal Malignancies in Short Bowel Syndrome Patients Treated With Teduglutide: Results From TriNetX?

S3024 Risks of Gastrointestinal Malignancies in Short Bowel Syndrome Patients Treated With Teduglutide: Results From TriNetX has closed oa status in the ScholarIQ index.

What is the DOI of S3024 Risks of Gastrointestinal Malignancies in Short Bowel Syndrome Patients Treated With Teduglutide: Results From TriNetX?

The DOI for S3024 Risks of Gastrointestinal Malignancies in Short Bowel Syndrome Patients Treated With Teduglutide: Results From TriNetX is on the source record.

What is the OpenAlex record for S3024 Risks of Gastrointestinal Malignancies in Short Bowel Syndrome Patients Treated With Teduglutide: Results From TriNetX?

The OpenAlex for S3024 Risks of Gastrointestinal Malignancies in Short Bowel Syndrome Patients Treated With Teduglutide: Results From TriNetX is on the source record.